Trypanothione-dependent redox system (Trypanothione system)

The trypanothione-dependent redox system is a unique and essential metabolic pathway found in kinetoplastid parasites, including Leishmania species (Fairlamb & Cerami, 1992). Unlike their mammalian hosts, which rely on the glutathione/glutathione reductase system to maintain intracellular redox balance, Leishmania utilizes trypanothione [N1,N8-bis(glutathionyl)spermidine] as its primary low-molecular-weight thiol (Krauth-Siegel & Comini, 2008). This system is centered around the enzyme trypanothione reductase (TR), which maintains trypanothione in its reduced state to neutralize reactive oxygen and nitrogen species encountered during the parasite's life cycle (Cunningham et al., 1994). Because this system is essential for parasite survival and is absent in humans, it is a primary target for the development of anti-leishmanial therapies (Wyllie et al., 2004). Traditional drugs like pentavalent antimonials are believed to work by inhibiting TR and depleting the parasite's antioxidant capacity (Baiocco et al., 2009). Disruption of this system leads to the accumulation of oxidative damage, eventually triggering programmed cell death in the parasite (Paris et al., 2004). Modern drug discovery efforts aim to identify potent, non-toxic inhibitors of TR to address the increasing prevalence of drug-resistant Leishmania strains (Mandal et al., 2007).

Other names

Leishmania cellular thiol/redox systemTrypanothione metabolismThiol-based antioxidant system of LeishmaniaTrypanothione-dependent redox system

Inhibition of trypanothione reductase (TR), depletion of reduced trypanothione [T(SH)2] levels, and induction of lethal oxidative stress within the parasite (Baiocco et al., 2009; Wyllie et al., 2004).